TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Investor Investigation Over Possible Breaches Of Fiduciary Duties Announced

  • If you purchased shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and currently hold any of those NASDAQ:REGN shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Regeneron Pharmaceuticals Inc
Security
NASDAQ: REGN

Summary

July 13, 2015 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Regeneron Pharmaceuticals.

The investigation by a law firm concerns whether certain Regeneron Pharmaceuticals officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Regeneron Pharmaceuticals Inc reported that its annual Total Revenue rose from $2.1 million in 2013 to over $2.81 billion in 2014 and its Net Income declined from $424.36 million in 2013 to $348.07 million in 2014. Shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) grew from $269.59 per share in December 2013 to as high as $539.40 per share in June 2015.

Start Monitoring Your Investments